GlassScriptPhysician profile
Todd Robert Panzer
NPI 1952466351
$948.25
in general payments reported to CMS, 2019-2025
14 companies · $87.50 in 2025
The $87.50 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $122 · 2022: $41.81 · 2023: $320 · 2024: $377 · 2025: $87.50.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $785.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $784.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $279.93 | 2024 | |
| Stryker Corporation | $174.45 | 2023 | Mako |
| Amgen INC. | $150.28 | 2021-2025 | Otezla, Repatha, Repatha |
| Novo Nordisk INC | $114.39 | 2021-2024 | Wegovy, Ozempic, Rybelsus |
| Pfizer INC. | $66.17 | 2021-2023 | |
| Idorsia Pharmaceuticals US INC | $28.54 | 2023 | Quviviq |
| Exact Sciences Corporation | $24.66 | 2023 | Cologuard Collection Kit |
| Pharming Healthcare, INC. | $19.68 | 2024 | Ruconest |
| Gilead Sciences, INC. | $16.37 | 2021 | |
| Lilly USA, LLC | $16.27 | 2022 | |
| Glaxosmithkline, LLC. | $15.45 | 2024 | Trelegy Ellipta |
| Merck Sharp & Dohme LLC | $15.39 | 2024 | Vaxneuvance, Vaqta, Vaxelis |
| Abbvie INC. | $13.87 | 2023 | |
| Nestle Healthcare Nutrition INC. | $12.80 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Todd Panzer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.